Global Superdisintegrants Market Size study, by Type (Natural, Synthetics, Others), Formulation (Tablets, Capsules), Therapeutic Area (Neurological Diseases, Gastrointestinal Diseases, Oncology, Inflammatory Diseases, Infectious Diseases, Cardiovascular Diseases, Hematological Diseases) and Regional Forecasts 2019-2026

Published by Bizwit Research & Consulting | On Sep-2019 | Pages : 200 | Report ID : 813374

Global superdisintegrants market is valued at approximately USD 349.60 million in 2018 and is anticipated to grow with a healthy growth rate of more than 8.10% over the forecast period 2019-2026. Superdisintegrants are combination of substances added to drug formulation that accelerates the disintegration of capsule content or tablets into smaller particles which easily gets dissolved. Increasing adoption of oral disintegrating tablets is one of the major driving factors of global superdisintegrants market. In addition, shifting focus of pharmaceutical manufacturers towards emerging markets is an added advantage for the growth of market. However, less expenditure in R&D activities restricts the market to grow with the expected rate. For instance, the fragmentation of the EU pharmaceutical market resulted in lucrative parallel trade. Neither social security nor patients are benefitted with this and leads to deprival of additional resources for funding R&D. The regional analysis of global Superdisintegrants market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to rising adoption of synthetic superdisintegrants. Europe also contributes a satisfactory growth in the global Superdisintegrants market due to rising population affected by neurological diseases. Asia-Pacific is also anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026 due to increasing preference to ODTs in developing countries such as India China and Japan. The leading market player included in this report are: BASF SE DowDuPont Inc. Roquette Freres DFE Pharma JRS Pharma Asahi Kasei Corporation Merck KGaA Corel Pharma Chem Avantor Performance Materials, LLC Ashland Global Holdings Inc. The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: By Type: Natural Synthetic Others By Formulation: Tablets Capsules By Therapeutic Area: Neurological Diseases Gastrointestinal Diseases Oncology Inflammatory Diseases Infectious Diseases Cardiovascular Diseases Hematological Diseases By Regions: North America U.S. Canada Europe UK Germany Asia Pacific China India Japan Latin America Brazil Mexico Rest of the World Furthermore, years considered for the study are as follows: Historical year ? 2016, 2017 Base year ? 2018 Forecast period ? 2019 to 2026 Target Audience of the Global Superdisintegrants Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value-Added Resellers (VARs) Third-party knowledge providers Investment bankers Investors